Recombinant multi-species Calsyntenin-1/CLSTN1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Calsyntenin-1/CLSTN1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene is a member of the calsyntenin family, a subset of the cadherin superfamily. The encoded transmembrane protein, also known as alcadein-alpha, is thought to bind to kinesin-1 motors to mediate the axonal anterograde transport of certain types of vesicle. Amyloid precursor protein (APP) is trafficked via these vesicles and so this protein is being investigated to see how it might contribute to the mechanisms underlying Alzheimer's disease. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014]
The Alternative Names of target: 1810034E21Rik,ALC-ALPHA,Alcadein-alpha (Alc-alpha),Alzheimer-related cadherin-like protein,CDHR12,CLSTN1,CST-1,CSTN1,Calsyntenin-1,Clstn1,Cst-1,Cstn1,Non-classical cadherin XB31alpha,PIK3CD,XB31alpha,alcalpha1,alcalpha2

Target products collectionGo to Calsyntenin-1/CLSTN1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE0098-Ag-1/ GM-Tg-hg-SE0098-Ag-2 Human Calsyntenin-1/CLSTN1 protein Human
GM-Tg-rg-SE0098-Ag-1/ GM-Tg-rg-SE0098-Ag-2 Rat Calsyntenin-1/CLSTN1 protein Rat
GM-Tg-mg-SE0098-Ag-1/ GM-Tg-mg-SE0098-Ag-2 Mouse Calsyntenin-1/CLSTN1 protein Mouse
GM-Tg-cynog-SE0098-Ag-1/ GM-Tg-cynog-SE0098-Ag-2 Cynomolgus/Rhesus macaque Calsyntenin-1/CLSTN1 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE0098-Ag-1/ GM-Tg-felg-SE0098-Ag-2 Feline Calsyntenin-1/CLSTN1 protein Feline
GM-Tg-cang-SE0098-Ag-1/ GM-Tg-cang-SE0098-Ag-2 Canine Calsyntenin-1/CLSTN1 protein Canine
GM-Tg-bovg-SE0098-Ag-1/ GM-Tg-bovg-SE0098-Ag-2 Bovine Calsyntenin-1/CLSTN1 protein Bovine
GM-Tg-equg-SE0098-Ag-1/ GM-Tg-equg-SE0098-Ag-2 Equine Calsyntenin-1/CLSTN1 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE0098-Ag-1/ GM-Tg-hg-SE0098-Ag-2; GM-Tg-rg-SE0098-Ag-1/ GM-Tg-rg-SE0098-Ag-2;
GM-Tg-mg-SE0098-Ag-1/ GM-Tg-mg-SE0098-Ag-2; GM-Tg-cynog-SE0098-Ag-1/ GM-Tg-cynog-SE0098-Ag-2;
GM-Tg-felg-SE0098-Ag-1/ GM-Tg-felg-SE0098-Ag-2; GM-Tg-cang-SE0098-Ag-1/ GM-Tg-cang-SE0098-Ag-2;
GM-Tg-bovg-SE0098-Ag-1/ GM-Tg-bovg-SE0098-Ag-2; GM-Tg-equg-SE0098-Ag-1/ GM-Tg-equg-SE0098-Ag-2
Products Name Calsyntenin-1/CLSTN1 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name Calsyntenin-1/CLSTN1
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Calsyntenin-1/CLSTN1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.